OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. Various strategies have been employed enhance antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion processes. Fine-tuning growth parameters play